Please login to the form below

Not currently logged in
Email:
Password:

Trulicity

This page shows the latest Trulicity news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk boosted by new type 2 diabetes launches

Novo Nordisk boosted by new type 2 diabetes launches

Although Ozempic still has some way to go, these trials are likely an effort to expand the drug’sindications as it hopes to prove dominance over Trulicity.

Latest news

  • Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12% Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12%

    Novo looking to challenge with oral semaglutide. Eli Lilly has put the flesh on the bones of its REWIND cardiovascular outcomes study for diabetes drug Trulicity, a key element in its ... It is already trumpeting data showing Ozempic seems to be superior

  • Lilly claims cluster headache first for CGRP drug Emgality Lilly claims cluster headache first for CGRP drug Emgality

    IL-23 inhibitor Skyrizi (risankizumab), and top-selling diabetes therapy Trulicity (dulaglutide) is also under pricing pressure.

  • Pricing pressures peg back Lilly’s growth products Pricing pressures peg back Lilly’s growth products

    Lower-than-expected sales for psoriasis drug Taltz (ixekizumab) and Trulicity (dulaglutide) for diabetes were put down to increasing demand in the US market for rebates and discounts. ... That scenario also applied to Trulicity – the first once-weekly

  • Novo uses voucher for speedy answer on oral semaglutide Novo uses voucher for speedy answer on oral semaglutide

    The company also released headline results last September from the Pioneer 10 head-to-head trial of oral semaglutide versus its biggest rival, Eli Lilly's Trulicity, which suggested superiority on ... Lilly’s weekly GLP-1 agonist Trulicity brought in

  • Trulicity’s ascent lifts Lilly Trulicity’s ascent lifts Lilly

    Diabetes treatment leads new product growth. Impressive growth from diabetes treatment Trulicity has helped Eli Lilly to post 7% growth in its full year results. ... Trulicity revenues rose 42% to $924.7m in the fourth quarter, with US revenues up a

More from news
Approximately 8 fully matching, plus 34 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you in the world of the patient...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics